The UFE market has decreased over the past couple of years as there has been a reduction of active marketing. Moreover, UFE must compete with a wide array of procedures available to treat heavy bleeding due to uterine fibroids. These other treatments and procedures include hysterectomy, pharmacological alternatives, global endometrial ablation, endometrial resection and other minimally invasive surgical procedures. For more price-sensitive countries, such as France, Spain, Italy and Portugal, alternative treatments present significant competition as patients and physicians look for inexpensive methods for the management or treatment of uterine fibroids. Moreover, because of the economic situation, many women are delaying surgical treatments.
'
TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
PROCEDURE NUMBERS 11
MARKETS INCLUDED 12
KEY REPORT UPDATES 14
VERSION HISTORY 17
RESEARCH METHODOLOGY 18
1.1 RESEARCH SCOPE 18
1.2 IDATA’S 9-STEP METHODOLOGY 18
1.2.1 Step 1: Project Initiation & Team Selection 18
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 20
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design 21
1.2.4 Step 4: Performing Primary Research 22
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 24
1.2.6 Step 6: Market Forecast and Analysis 25
1.2.7 Step 7: Identify Strategic Opportunities 27
1.2.8 Step 8: Final Review and Market Release 28
1.2.9 Step 9: Customer Feedback and Market Monitoring 29
COUNTRY PROFILES 30
2.1 INTRODUCTION 30
2.1.1.1 Population 30
2.1.1.2 Median Age 32
2.1.1.3 GDP Per Capita 32
2.1.1.4 Price Index 33
2.2 GERMANY 34
2.3 FRANCE 35
2.4 UNITED KINGDOM 36
2.5 ITALY 37
2.6 SPAIN 38
2.7 BENELUX 39
2.8 SCANDINAVIA 40
2.9 AUSTRIA 41
2.10 SWITZERLAND 43
2.11 PORTUGAL 44
UTERINE FIBROID EMBOLIZATION DEVICE MARKET 45
3.1 INTRODUCTION 45
3.1.1 Microspheres 46
3.1.2 Polyvinyl Alcohol Particles 46
3.1.3 Drug-eluting Particles 46
3.2 MARKET OVERVIEW 47
3.3 MARKET ANALYSIS AND FORECAST 51
3.3.1 Uterine Fibroid Embolization Procedures 51
3.3.1.1 Microspheres Market 59
3.3.1.2 PVA Particles Market 67
3.4 DRIVERS AND LIMITERS 75
3.4.1 Market Drivers 75
3.4.2 Market Limiters 75
3.5 COMPETITIVE MARKET SHARE ANALYSIS 78
ABBREVIATIONS 81
Chart 1 1: Gynecological Device Market by Segment, Europe, 2012 – 2022 3
Chart 1 2: Gynecological Device Market Overview, Europe, 2015 & 2022 3
Chart 2 1: Country Profile, Germany, 2015 34
Chart 2 2: Country Profile, France, 2015 35
Chart 2 3: Country Profile, United Kingdom, 2015 36
Chart 2 4: Country Profile, Italy, 2015 37
Chart 2 5: Country Profile, Spain, 2015 38
Chart 2 6: Country Profile, Benelux, 2015 39
Chart 2 7: Country Profile, Scandinavia, 2015 40
Chart 2 8: Country Profile, Austria, 2015 42
Chart 2 9: Country Profile, Switzerland, 2015 43
Chart 2 10: Country Profile, Portugal, 2015 44
Chart 3 1: Uterine Fibroid Embolization Device Market by Segment, Europe, 2015 49
Chart 3 2: Uterine Fibroid Embolization Device Market Breakdown, Europe, 2015 50
Chart 3 3: Uterine Fibroid Embolization Device Market Breakdown, Europe, 2022 50
Chart 3 4: Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 53
Chart 3 5: Microspheres Market, Europe, 2012 – 2022 60
Chart 3 6: PVA Particles Market, Europe, 2012 – 2022 68
Chart 3 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Europe, 2015 80
Figure 1 1: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 3) 4
Figure 1 2: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 3) 5
Figure 1 3: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2015 6
Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Gynecological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Gynecological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in Gynecological Device Market, Europe, 2012 – 2016 10
Figure 1 9: Gynecological Procedures Covered, Europe, 2015 11
Figure 1 10: Gynecological Device Markets Covered, Europe, 2015 (1 of 2) 12
Figure 1 11: Gynecological Device Markets Covered, Europe, 2015 (2 of 2) 13
Figure 1 12: Key Report Updates (1 of 3) 14
Figure 1 13: Key Report Updates (2 of 3) 15
Figure 1 14: Key Report Updates (3 of 3) 16
Figure 1 15: Version History 17
Figure 2 1: Population by Country, Europe, 2015 30
Figure 2 2: Population, Benelux, 2015 31
Figure 2 3: Scandinavia, Europe, 2015 31
Figure 2 4: GDP per Capita, Europe, 2015 32
Figure 3 1: Uterine Fibroid Embolization Device Market by Segment, Europe, 2012 – 2022 (€M) 48
Figure 3 2: Uterine Fibroid Embolization Device Market by Segment, Europe, 2012 – 2022 (US$M) 48
Figure 3 3: Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (€ and US$) 52
Figure 3 4: Units Sold by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 54
Figure 3 5: Average Selling Price by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (€) 55
Figure 3 6: Average Selling Price by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (US$) 56
Figure 3 7: Market Value by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (€M) 57
Figure 3 8: Market Value by Country, Uterine Fibroid Embolization Device Market, Europe, 2012 – 2022 (US$M) 58
Figure 3 9: Microspheres Market, Europe, 2012 – 2022 (€ and US$) 59
Figure 3 10: Units Sold by Country, Microspheres Market, Europe, 2012 – 2022 61
Figure 3 11: Units per Procedure, Microspheres Market, Europe, 2012 – 2022 62
Figure 3 12: Average Selling Price by Country, Microspheres Market, Europe, 2012 – 2022 (€) 63
Figure 3 13: Average Selling Price by Country, Microspheres Market, Europe, 2012 – 2022 (US$) 64
Figure 3 14: Market Value by Country, Microspheres Market, Europe, 2012 – 2022 (€M) 65
Figure 3 15: Market Value by Country, Microspheres Market, Europe, 2012 – 2022 (US$M) 66
Figure 3 16: PVA Particles Market, Europe, 2012 – 2022 (€ and US$) 67
Figure 3 17: Units Sold by Country, PVA Particles Market, Europe, 2012 – 2022 69
Figure 3 18: Units per Procedure, PVA Particles Market, Europe, 2012 – 2022 70
Figure 3 19: Average Selling Price by Country, PVA Particles Market, Europe, 2012 – 2022 (€) 71
Figure 3 20: Average Selling Price by Country, PVA Particles Market, Europe, 2012 – 2022 (US$) 72
Figure 3 21: Market Value by Country, PVA Particles Market, Europe, 2012 – 2022 (€M) 73
Figure 3 22: Market Value by Country, PVA Particles Market, Europe, 2012 – 2022 (US$M) 74
Figure 3 23: Drivers and Limiters, Uterine Fibroid Embolization Device Market, Europe, 2015 77
Figure 3 24: Leading Competitors by Country, Uterine Fibroid Embolization Device Market, Europe, 2015 79
Bayer
Karl Storz
Cooper Surgical
Olympus
Richard Wolf
Cook Medical
Johnson & Johnson
Astora Women's Health
Vitrolife
Boston Scientific
Johnson & Johnson
Hologic
